About InnoCore

Meet the team, experience our expertise and unsurpassed drive to provide solutions

InnoCore specializes in formulation, process development and manufacturing of long acting and minimally invasive injectable drug delivery products. Our target-driven and cost-efficient organization is committed to delivering products and services that offer added value to our partners and improve the quality of life of patients. Flexibility, compliance with the highest international quality standards and a true belief in the value of collaborative partnerships are the key elements of the InnoCore approach. InnoCore is a privately owned company and is based in The Netherlands.

 

Team

 

InnoCore has an enthusiastic and dedicated team consisting of 50 people with a multidisciplinary background.

Scientists, polymer chemists, process engineers and analytical specialist  are working close together. The target driven team is committed delivering products and services that offer added value to our partners and improve the quality of life of patients.

 

Mission

InnoCore is dedicated to develop, in close collaboration with its pharma and biotech partners, minimally invasive and long-acting injectable polymer based depot formulation products for precise delivery of small molecules, peptides and protein therapeutics as to contribute to enhanced patient care.

History

  • > 12 feasibility projects ongoing for e.g. 3 of the top 10 Pharma/Biotech companies

  • Acquisition of minority stake in InGell Holding

  • InnoCore signs an Exclusive License with Allergan on Ophthalmology

     

  • CE Mark for SynBiosys containing product with Orbus Neich. 

  • Reallocation to the current lab/office facility

  • InnoCore continued development of the polymeric platform resulted in the SynBiosys Pro family; suitable for bio-therapeutic compounds especially proteins.

  • InnoCore established a License in the field of device coatings with its US partner Surmodics Inc.

  • Foundation of InnoCore